About

Publications While At HealthPartners

selected publications

Journal Article

Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. 

Cancer medicine. 2020

Randomized phase II trial of cisplatin and etoposide in combination with veliparib or placebo for extensive-stage small-cell lung cancer: ECOG-ACRIN 2511 Study. 

Journal of Clinical Oncology. 2019

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. 

Annals of Oncology. 2017

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer. 

Cancer Chemotherapy and Pharmacology. 2017

A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates. 

American Journal of Clinical Oncology. 2012

Radon testing and mitigation: an intervention in a primary care setting. 

Journal of Cancer Education. 2012

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction. 

Annals of Surgical Oncology. 2011

Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. 

Journal of Oral and Maxillofacial Surgery. 2009

Case-control study to evaluate predictors of lymphedema after breast cancer surgery. 

Oncology Nursing Forum. 2009

Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy. 

Journal of Supportive Oncology. 2009

Contact

full name

J. W. Leach

Quick Info

 

Collaboration

Co-author network

Map of science